rfk and glp 1 User Clip: Jr's Thoughts on GLP-1 agonists Study Links GLP-1s to Lower

Oxidative stress in renal health

doi: 10.2337/dc18-0253

"Weight loss and changes in nutritional status, common consequences of GLP-1 receptor agonist therapy, are established risk factors for telogen effluvium, a common and typically transient form of non-scarring hair loss, providing a plausible biological mechanism for this association," write the researchers

The change was part of a larger anti-obesity initiative in a state where 36% of all adults were considered obese in 2023, a higher rate than all but a dozen other states, according to the most recent data from the Centers for Disease Control and Prevention